ctrl K

LakeShore Biopharma Co. L... (LSB)

NASDAQ: LSB · Real-Time Price · USD

1.25

0.05 (4.17%)

At close: May 01, 2025, 2:43 PM

1.23

-1.60%

After-hours: May 01, 2025, 06:49 PM EDT

LakeShore Biopharma Ltd Income Statement

Financials in CNY. Fiscal year is April - March.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	573.42M	687.2M	502.95M	257.02M
Cost of Revenue	117.69M	153.36M	117.07M	59.66M
Gross Profit	455.73M	533.84M	385.88M	197.36M
Operating Income	-445.83M	-139.38M	-549.18K	-125.85M
Interest Income	n/a	n/a	n/a	n/a
Pretax Income	-455.19M	-144.35M	-545.73K	-174.37M
Net Income	-433.46M	-145.48M	-545.73K	-191.83M
Selling & General & Admin	428.09M	333.32M	549.18K	208.33M
Research & Development	302.8M	318.7M	211.22M	94.39M
Other Expenses	170.67M	-199.45K	-2.41M	-22.36M
Operating Expenses	901.56M	647.15M	549.18K	319.68M
Interest Expense	44.34M	30.86M	2.72M	29.69M
Selling & Marketing Expenses	280.45M	251.56M	165.72M	69.44M
Cost & Expenses	1.02B	800.51M	549.18K	379.33M
Income Tax Expense	-21.73M	1.13M	4.94M	17.45M
Shares Outstanding (Basic)	106.92M	77.42M	29.5M	28.75M
Shares Outstanding (Diluted)	106.92M	77.42M	29.5M	28.75M
EPS (Basic)	-4.05	-1.88	-0.02	-6.67
EPS (Diluted)	-4.05	-1.88	-0.02	-6.67
EBITDA	-368.66M	-76.8M	-67.2M	-116.78M
EBIT	-410.85M	-113.49M	-98.35M	-144.68M
Depreciation & Amortization	42.19M	36.69M	31.15M	27.91M